This familiar diagnosis of “rhinitis”

The article highlights that rhinitis is the most common disease, it is divided into 3 main phenotypes: infectious (IR), allergic (AR) and non-infectious non-allergic (NAR). There are also combined forms.

IR is a viral disease. Its clinical picture is described, the frequent failure of patients to consult a doctor for this disease is noted, which contributes to the development of complications and its chronization.

The authors described the characteristic features of the AR clinic with “oral Allergy syndrome“.

It is noted that NAR is a heterogeneous disease, which is divided into at least 6 subphenotypes: drug, taste, hormonal, atrophic, idiopathic and rhinitis of older people. The authors analyze the reasons for their occurrence. There is also a professional form of rhinitis.

All these phenotypes are United by the symptom of difficult nasal breathing, which also occurs in chronic rhinosinusitis and “empty nose“ syndrome.

Other causes of nasal breathing disorders are also mentioned.

In the treatment of patients with almost any of the rhinitis phenotypes, the main ones are irrigation-elimination therapy and the appointment of topical decongestants (TD). An important role is played by avoiding the causes that activate the course of rhinitis, and educating the population to properly organize the individual treatment process.

Topical vasoconstrictor drugs are the leading topical remedies that eliminate nasal breathing difficulties. They are sold in our country in the usual access and if used incorrectly can cause the development of medical rhinitis and many serious consequences. The methods of correct administration of the drug in the form of drops and spray, as well as its age-related dosages, are disclosed

rhinitis, infectious rhinitis, allergic rhinitis, drug-induced rhinitis, hormonal rhinitis, atrophic rhinitis, idiopathic rhinitis, professional rhinitis, nasal breathing difficulties, empty nose syndrome, irrigation and elimination therapy, topical decongestants, oxymetazoline

1. Roberts G., Xatzipsalti M., Borrego L.M., Custovic A., Halken S., Hellings P.W. et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013;68(9):1102–1116. doi: 10.1111/all.12235.

2. Akdis C.A., Bachert C., Cingi C., Dykewicz M.S., Hellings P.W., Naclerio R.M. et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131(6):1479–1490. doi: 10.1016/j.jaci.2013.02.036.

3. Akdis C.A., Bachert C., Cingi C., Dykewicz M.S., Hellings P.W., Naclerio R.M. et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131(6):1479–1490. doi: 10.1016/j.jaci.2013.02.036.

4. Zuberbier T., Lotvall J., Simoens S., Subramanian S.V., Church M.K. Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy. 2014;69(10):1275–1279. doi: 10.1111/all.12470.

5. Meltzer E.O., Blaiss M.S., Naclerio R.M., Stoloff S.W., Derebery M.J., Nelson H.S. et al. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc. 2012;33:113–141. doi: 10.2500/aap.2012.33.3603.

6. Kryukov A.I., Kunelskaya N.L., Izotova G.N., Gurov A.V., Yushkina M.A., Sokolov S.A. Approaches TO acute rhinitis therapy. Meditsinskiy sovet = Medical Council. 2016;(9):45–47. (In Russ.) doi: 10.21518/2079-701X2016-9-45-47.

7. Hens G., Vanaudenaerde B.M., Bullens D.M., Piessens M., Decramer M., Dupont L.J. et al. Sinonasal pathology in nonallergic asthma and COPD: ‘united airway disease’ beyond the scope of allergy. Allergy. 2008;63(3):261–267. doi: 10.1111/j.1398-9995.2007.01545.x.

8. Chakrabarti A., Denning D.W., Ferguson B.J., Ponikau J., Buzina W., Kita H. et al. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope. 2009;119(9):1809–1818. doi: 10.1002/lary.20520.

9. Tran N.P., Vickery J., Blaiss M.S. Management of rhinitis: allergic and nonallergic. Allergy Asthma Immunol Res. 2011;3(3):148–156. doi: 10.4168/aair.2011.3.3.148.

10. Greiner A.N., Meltzer E.O. Overview of the treatment of allergic rhinitis and nonallergic rhinopathy. Proc Am Thorac Soc. 2011;8(1):121–131. doi: 10.1513/pats.201004-033RN.

11. Ciprandi G., Cirillo I. Monosensitization and polysensitization in allergic rhinitis. Eur J Intern Med. 2011;22(6):75–79. doi: 10.1016/j.ejim.2011.05.009.

12. Tarasova G.D. (ed.) Allergic rhinoconjunctivitis in children. Moscow: GEOTARMedia; 2017. 128 p. (In Russ.) Available at: https://www.rosmedlib.ru/book/ISBN9785970439555.html.

13. Mokronosova M.A., Zheltikova T.M., Tarasova G.D. Elimination therapy of intermittent rhinitis. Rossiyskiy allergologicheskiy zhurnal = Russian Journal of Allergy. 2008;5(4):74–78. Available at: http://rusalljournal.ru/sc/pdf/4-2008.pdf.

14. Sergeev A.V., Mokronosova M.A. Oral allergy syndrome. Meditsinskaya immunologiya = Medical Immunology (Russia). 2011;13(1):17–28. (In Russ.) doi: 10.15789/1563-0625-2011-1-17-28.

15. Burns P., Powe D.G., Jones N.S. Idiopathic rhinitis. Curr Opin Otolaryngol Head Neck Surg. 2012;20(1):1–8. doi: 10.1097/MOO.0b013e32834e8ef7.

16. Rondon C., Campo P., Togias A., Fokkens W.J., Durham S.R., Powe D.G. et al. Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol. 2012;129(6):1460–1467. doi: 10.1016/j.jaci.2012.02.032.

17. Molgaard E., Thomsen S.F., Lund T., Pedersen L., Nolte H., Backer V. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy. 2007;62(9):1033–1037. doi: 10.1111/j.1398-9995.2007.01355.x.

18. Settipane R.A., Charnock D.R. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19:23–34. Available at https://pubmed.ncbi.nlm.nih.gov/17153005/

19. Scarupa M.D., Kaliner M.A. Nonallergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations. WAO J. 2009;2(3):20–25. doi: 10.1097/WOX.0b013e3181990aac.

20. Salib R.J., Harries P.G., Nair S.B., Howarth P.H. Mechanisms and mediators of nasal symptoms in non-allergic rhinitis. Clin Exp Allergy. 2008;38(3):393–404. doi: 10.1111/j.1365-2222.2007.02926.x.

21. Rondon C., Canto G., Blanca M. Local allergic rhinitis: a new entity, haracterization and further studies. Curr Opin Allergy Clin Immunol. 2010;10(1):1–7. doi: 10.1097/ACI.0b013e328334f5fb.

22. Kaliner M. Classification of Nonallergic Rhinitis Syndromes With a Focus on Vasomotor Rhinitis, Proposed to be known henceforth as Nonallergic Rhinopathy. WAO J. 2009;2:98–101. doi: 10.1097/WOX.0b013e3181a9d55b.

23. Ellegard E.K. Clnical and pathogenetic characteristics of pregnancy rhinitis. Clin Rev Allergy Immunol. 2004;26:149–159. doi: 10.1385/CRIAI:26:3:149.

24. Bachert C. Persistent rhinitis – allergic or nonallergic? Allergy. 2004;59(s76):11–15. doi: 10.1111/j.0108-1675.2004.00389.x.

25. Georgalas C., Jovancevic L. Gustatory rhinitis. Curr Opin Otolaryngol Head Neck Surg. 2012;20(1):9–14. doi: 10.1097/MOO.0b013e32834dfb52.

26. Jovancevic L., Georgalas C., Savovic S., Janjevic D. Gustatory rhinitis. Rhinology. 2010;48(1):7–10. doi: 10.4193/Rhin07.153.

27. Rukhadze M., Gotua M., Gamkrelidze A. Drug-induced rhinitis. Curr Treat Options Allergy. 2016;3:69–84. doi: 10.1007/s40521-016-0076-2.

28. Knipping S., Holzhausen H., Goetze G., Roederer A., Blocking M.B. Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa. Otolaryngol Head Neck Surg. 2007;136(1):57–61. doi: 10.1016/j.otohns.2006.08.025.

29. Sarin S., Undem B., Sanico A., Togias A. The role of the nervous system in rhinitis. J Allergy Clin Immunol. 2006;118(5):999–1016. doi: 10.1016/j.jaci.2006.09.013.

30. Buleeva I.M., Dvoretskiy L.I. Churg-Strauss Syndrome case. Clinical observation. RMZh = RMJ. 2009;(23):15–39. (In Russ.) Available at: https://www.rmj.ru/articles/revmatologiya/Sluchay_sindroma_ChergaStraussa__Klinicheskoe_nablyudenie/

31. Nathan R.A., Dalal A.A., Stanford R.H., Meltzer E.O., Schatz M., Derebery J. et al. Qualitative development of the rhinitis control assessment test (RCAT), an instrument for evaluating rhinitis symptom control. Patient. 2010;3(2):91–99. doi: 10.2165/11318410-000000000-00000.

32. Demoly P., Jankowski R., Chassany O., Bessah Y., Allaert F.A. Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin Exp Allergy. 2011;41(6):860–868. doi: 10.1111/j.1365-2222.2011.03734.x.

33. Fokkens W.J., Lund V.J., Mullol J., Bachert C., Alobid I., Baroody F. et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1–12. doi: 10.4193/Rhino50E2.

34. Brozek J.L., Bousquet J., Agache I., Agarwal A., Bachert C., Bosnic-Anticevch S. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi: 10.1016/j.jaci.2017.03.050.

35. Brozek J.L., Bousquet J., Agache I., Agarwal A., Bachert C., Bosnic-Anticevch S. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi: 10.1016/j.jaci.2017.03.050.

36. Sheikh A., Hurwitz B., Shehata YA. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev. 2007;(1):CD001563. doi: 10.1002/14651858.CD001563.pub2.

37. Bernstein J.A., Alexis N., Bacchus H., Bernstein I.L., Fritz P., Horner E. et al. The health effects of non-industrial indoor air pollution. J Allergy Clin Immunol. 2008;121(3):585–591 doi: 10.1016/j.jaci.2007.10.045.

38. Mastin T. Recognizing and treating non-infectious rhinitis. J Am Acad Nurse Pract. 2003;15(9):398–409. doi: 10.1111/j.1745-7599.2003.tb00414.x.

39. Harvey R., Hannan S.A., Badia L., Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;(3):CD006394. doi: 10.1002/14651858.CD006394.pub2.

40. Watanabe H., Foo T.H., Djazaeri B., Duncombe P., Mackay I.S., Durham S.R. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Rhinology. 2003;41(3):167–174. Available at: https://pubmed.ncbi.nlm.nih.gov/14579657.

41. Sahin G., Klimek L., Mullol J., Hörmann K., Walther L.E., Pfaar O. Nitric oxide: a promising methodological approach in airway diseases. Int Arch Allergy Immunol. 2011;156(4):352–361. doi: 10.1159/000324678.

42. Stringer S.P., Mancuso A.A., Avino A.J. Effect of a topical vasoconstrictor on computed tomography of paranasal sinus disease. Laryngoscope. 1993;103(1-1):6–9. doi: 10.1288/00005537-199301000-00002.

43. Pullerits T., Praks L., Ristioja V., Lotvall J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2002;109(6):949–955. doi: 10.1067/mai.2002.124467.

44. Miroshnichenko N.A., Ovchinnikov A.Y. Topical decongestants: myth and reality. Meditsinskiy sovet = Medical Council. 2018;(12):40–43. (In Russ.) doi: 10.21518/2079-701X-2018-12-40-43.

45. Morozova S.V., Toporkova L.A. The use of nasal decongestants to correction the respiratory and olfactory function of the nose. Meditsinskiy sovet = Medical Council. 2019;(8):60–65. (In Russ.) doi: 10.21518/2079-701X-2019-8-60-65.